TITAN:COMMENCENCT02860364
Comparing Hypothermic Temperatures During Hemiarch Surgery
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary endpoint(s) modified.
See at-risk trials from Ottawa Heart Institute Research Corporation
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 18 versions: 17 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary endpoint(s) modified Show 5 more changesShow less
- Eligibility criteria revised
- Enrollment increased: 282 → 328 participants
- Study sites: 12 to 14
- Secondary endpoints revised (12)
- Publications: details revised at 1 of 1 entry
- Notable Primary and study completion dates pushed to Dec 2030
- Study sites: 21 to 12
- Minor Site details revised at 1 of 21 sitesv16
- Minor Study sites: 10 to 21v15
- Notable Primary completion date: Feb 2023 to Feb 2025
- Study completion date: Sep 2023 to Sep 2025
Show 11 earlier versionsHide 11 earlier versions
- Minor Study sites: 3 to 10v13
- Notable Trial status: Active, Not Recruiting to Recruiting
- Primary completion date: Jan 2021 to Feb 2023
- Study sites: 4 to 3
- Study completion date: Sep 2021 to Sep 2023
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised at 4 of 4 sites
- Minor Study sites: 2 to 4v9
- Notable Primary completion date: Jan 2019 to Jan 2021
- Study completion date: Sep 2019 to Sep 2021
Notable Enrollment target: 100 to 282v7 Show 5 more changesShow less
- Eligibility criteria expanded, about 38 words
- Primary endpoint revised
- Study sites: 1 to 2
- Secondary endpoints: 1 to 12
- Study title shortened, about 2 words
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jan 2018 to Feb 20, 2018
- Site details revised
- Notable Start date: Nov 2017 to Jan 2018v5
- Notable Start date: Jun 2017 to Nov 2017v4
- Notable Start date: Jan 2017 to Jun 2017v3
- Notable Start date: Sep 2016 to Jan 2017v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Hierarchical Composite of Mortality, Stroke, Transient Ischemic Attack, Acute Kidney Injury, and Perioperative Bleeding
Timeframe: Up to 90 days after surgery.
Secondary (12)
Rates of Neurologic Injury
Incidence of Acute Kidney Injury (AKI)
Incidence of Delirium
Death
Evaluate differences in the duration of cardiopulmonary bypass used in patients who receive mild or moderate hypothermic circulatory arrest during aortic hemiarch surgery
Show 7 moreShow less
Rates of Mediastinal re-exploration for bleeding
Incidence and quantity of perioperative blood transfusions
Incidence of prolonged Mechanical Ventilation
Perioperative Myocardial Infarction
Length of Stay
Quality of life (SF-12)
Incidence of Perioperative Bleeding (UDPB Class 2 or Higher)
Arms and interventions
Mild Hypothermic Circulatory ArrestExperimental
During aortic hemiarch surgery, mild hypothermia (32°C) will be used during circulatory arrest.
Moderate Hypothermic Circulatory ArrestActive comparator
During aortic hemiarch surgery, moderate hypothermia (26°C) will be used during circulatory arrest.
Procedures: Hypothermic circulatory arrest
Sites
14 sites in 2 countries
Canada 11, United States 3